S095035 in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of the Methylthioadenosine Phosphorylase (MTAP) Gene
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06188702 |
Recruitment Status :
Recruiting
First Posted : January 3, 2024
Last Update Posted : May 2, 2024
|
Sponsor:
Servier Bio-Innovation LLC
Collaborator:
Institut de Recherches Internationales Servier
Information provided by (Responsible Party):
Servier ( Servier Bio-Innovation LLC )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | May 1, 2026 |
Estimated Study Completion Date : | May 1, 2026 |